ATE321869T1 - Fusionproteine für intra- und interzelluläre transport und deren verwendungen - Google Patents

Fusionproteine für intra- und interzelluläre transport und deren verwendungen

Info

Publication number
ATE321869T1
ATE321869T1 AT98900953T AT98900953T ATE321869T1 AT E321869 T1 ATE321869 T1 AT E321869T1 AT 98900953 T AT98900953 T AT 98900953T AT 98900953 T AT98900953 T AT 98900953T AT E321869 T1 ATE321869 T1 AT E321869T1
Authority
AT
Austria
Prior art keywords
proteins
protein
transport
intra
coupled
Prior art date
Application number
AT98900953T
Other languages
English (en)
Inventor
Peter Francis Joseph O'hare
Gillian Daphne Elliott
Original Assignee
Marie Curie Cancer Care
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9701363.5A external-priority patent/GB9701363D0/en
Priority claimed from GBGB9716398.4A external-priority patent/GB9716398D0/en
Application filed by Marie Curie Cancer Care filed Critical Marie Curie Cancer Care
Application granted granted Critical
Publication of ATE321869T1 publication Critical patent/ATE321869T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/826—Viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT98900953T 1997-01-23 1998-01-23 Fusionproteine für intra- und interzelluläre transport und deren verwendungen ATE321869T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9701363.5A GB9701363D0 (en) 1997-01-23 1997-01-23 Materials and methods for intracellular transport and their uses
GBGB9716398.4A GB9716398D0 (en) 1997-08-01 1997-08-01 Fusion proteins for cell cycle control

Publications (1)

Publication Number Publication Date
ATE321869T1 true ATE321869T1 (de) 2006-04-15

Family

ID=26310846

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98900953T ATE321869T1 (de) 1997-01-23 1998-01-23 Fusionproteine für intra- und interzelluläre transport und deren verwendungen

Country Status (9)

Country Link
US (4) US6017735A (de)
EP (1) EP0961829B1 (de)
JP (1) JP2001508304A (de)
AT (1) ATE321869T1 (de)
AU (1) AU735830B2 (de)
CA (1) CA2278002A1 (de)
DE (1) DE69834022T2 (de)
ES (1) ES2264809T3 (de)
WO (1) WO1998032866A1 (de)

Families Citing this family (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5795587A (en) * 1995-01-23 1998-08-18 University Of Pittsburgh Stable lipid-comprising drug delivery complexes and methods for their production
US20030069173A1 (en) * 1998-03-16 2003-04-10 Life Technologies, Inc. Peptide-enhanced transfections
EP0845043B1 (de) * 1995-07-28 2007-06-27 Marie Curie Cancer Care Transportproteine und deren verwendungen
US6482586B1 (en) * 1996-11-22 2002-11-19 Hospital For Sick Children Research And Development Limited Partnership Hybrid compositions for intracellular targeting
US6017735A (en) * 1997-01-23 2000-01-25 Marie Curie Cancer Care Materials and methods for intracellular transport and their uses
GB9705903D0 (en) * 1997-03-21 1997-05-07 Elliott Gillian D VP22 Proteins and uses thereof
CA2319437C (en) 1998-01-31 2009-06-16 University Of Arkansas Methods and reagents for decreasing allergic reactions
GB9816761D0 (en) 1998-07-31 1998-09-30 Phogen Limited Herpesvirus preparations and their uses
DE19845420C2 (de) * 1998-10-02 2000-11-16 Deutsches Krebsforsch Interzelluläre Ausbreitung rekombinanter DNA
PT1129064E (pt) * 1998-11-12 2008-01-31 Invitrogen Corp Reagentes de transfecção
CA2366462C (en) * 1998-12-04 2011-08-09 University Of Manitoba Two-step immunization procedure against chlamydia infection
US6316252B1 (en) * 1998-12-17 2001-11-13 Wisconsin Alumni Research Foundation Biotherapeutic delivery system
DE60017211T2 (de) * 1999-02-17 2005-06-02 Pfizer Products Inc., Groton Fusionsproteine mit Trägern welche eine doppelte Immunantwort induzieren
DE60040274D1 (de) * 1999-03-10 2008-10-30 Phogen Ltd Verabreichung von nukleinsäuren und proteinen an zellen
JP2002539839A (ja) * 1999-03-31 2002-11-26 インヴィトロゲン・コーポレーション 転位ポリペプチドによる機能性タンパク質配列の送達
US6773920B1 (en) 1999-03-31 2004-08-10 Invitrogen Corporation Delivery of functional protein sequences by translocating polypeptides
US6451601B1 (en) 1999-04-12 2002-09-17 Modex Therapeutiques, S.A. Transiently immortalized cells for use in gene therapy
ATE342275T1 (de) * 1999-04-12 2006-11-15 Heart Biosystems Gmbh Vorübergehend-immortalisierte zellen zur verwendung in gentherapie
US6358739B1 (en) 1999-04-12 2002-03-19 Modex Therapeutiques, S.A. Transiently immortalized cells
US6673554B1 (en) * 1999-06-14 2004-01-06 Trellie Bioinformatics, Inc. Protein localization assays for toxicity and antidotes thereto
DE19933089A1 (de) * 1999-07-15 2001-01-18 Max Delbrueck Centrum Mittel zur Gewerbsregeneration
US6737511B1 (en) * 1999-08-16 2004-05-18 The United States Of America As Represented By The Department Of Health And Human Services Receptor-mediated uptake of an extracellular BCL-xL fusion protein inhibits apoptosis
US20030104622A1 (en) * 1999-09-01 2003-06-05 Robbins Paul D. Identification of peptides that facilitate uptake and cytoplasmic and/or nuclear transport of proteins, DNA and viruses
US20030219826A1 (en) * 1999-09-01 2003-11-27 Robbins Paul D. Identification of peptides that facilitate uptake and cytoplasmic and/or nuclear transport of proteins, DNA and viruses
WO2001015511A2 (en) 1999-09-01 2001-03-08 University Of Pittsburgh Of The Commonwealth System Of Higher Education Identification of peptides that facilitate uptake and cytoplasmic and/or nuclear transport of proteins, dna and viruses
US8128922B2 (en) 1999-10-20 2012-03-06 Johns Hopkins University Superior molecular vaccine linking the translocation domain of a bacterial toxin to an antigen
GB9930519D0 (en) 1999-12-24 2000-02-16 Phogen Limited Uses of transport proteins
IL150510A0 (en) * 2000-01-07 2003-02-12 Artemis Pharmaceuticals Gmbh Transduction of recombinases for inducible gene targeting
US20020025306A1 (en) * 2000-01-07 2002-02-28 Baetge Edward E. Methods of increasing the glucose responsiveness of pancreatic ss-cells
DE10001230A1 (de) * 2000-01-13 2001-08-02 Deutsches Krebsforsch Immunisierungsmittel
WO2001057091A1 (en) * 2000-02-01 2001-08-09 University Of Utah Research Foundation Soluble, chimeric transcription factors that enter cells to modulate cell differentiation and phenotype
US6688084B2 (en) * 2000-03-24 2004-02-10 International Paper Company Automated bulk box strapper
US7318928B2 (en) * 2000-08-01 2008-01-15 The Johns Hopkins University Molecular vaccine linking intercellular spreading protein to an antigen
EP1363938B1 (de) * 2000-08-03 2013-12-11 Johns Hopkins University An endoplasmatischen reticulums chaperonprotein gebundenes antigen als molekulärimpfstoff
GB0022101D0 (en) * 2000-09-08 2000-10-25 Phogen Ltd Delivery of substances to cells
US20020073441A1 (en) 2000-12-13 2002-06-13 Ross Brian D. Compositions and methods for detecting proteolytic activity
AU2002306736A1 (en) * 2001-03-16 2002-10-03 Johns Hopkins University A replication-defective alphavirus vaccine linking antigen with an immunogenicity-potentiating polypeptide and a method of delivery the same
GB0113552D0 (en) * 2001-06-05 2001-07-25 Secr Defence Vaccines
EP2191845A1 (de) * 2001-07-31 2010-06-02 University of Washington Immunologisch bedeutende Herpes-simplex-virus-antigene und Verfahren für ihre Verwendung
US20030119770A1 (en) * 2001-08-02 2003-06-26 Zhennan Lai Intercellular delivery of a herpes simplex virus VP22 fusion protein from cells infected with lentiviral vectors
JP2005506090A (ja) * 2001-10-18 2005-03-03 ハート・バイオシステムズ・ゲーエムベーバー 一時的な不死化
WO2003068190A1 (en) * 2002-02-13 2003-08-21 Northeastern University Intracellular delivery of therapeutic agents
AU2002318168B2 (en) 2002-02-25 2007-12-13 Vaxiion Therapeutics, Llc Minicell compositions and methods
WO2004015061A2 (en) * 2002-05-17 2004-02-19 Automated Cell, Inc. Determination of protein function
CA2513072A1 (en) * 2003-01-09 2004-07-29 Invitrogen Corporation Cellular delivery and activation polypeptide-nucleic acid complexes
US7534861B2 (en) * 2003-01-10 2009-05-19 Ambergen, Inc. Compositions and methods for immunoaffinity purification
GB0308988D0 (en) * 2003-04-17 2003-05-28 Univ Singapore Molecule
US9701725B2 (en) * 2003-05-05 2017-07-11 The Johns Hopkins University Anti-cancer DNA vaccine employing plasmids encoding signal sequence, mutant oncoprotein antigen, and heat shock protein
CA2529051A1 (en) * 2003-06-13 2004-12-29 The Trustees Of The University Of Pennsylvania Vaccines, immunotherapeutics and methods for using the same
ITRM20030376A1 (it) 2003-07-31 2005-02-01 Univ Roma Procedimento per l'isolamento e l'espansione di cellule staminali cardiache da biopsia.
CA2573176A1 (en) * 2004-07-09 2006-01-19 Bc Cancer Agency Nup98-hox fusions for expansion of hemopoietic stem cells
US11660317B2 (en) 2004-11-08 2023-05-30 The Johns Hopkins University Compositions comprising cardiosphere-derived cells for use in cell therapy
AU2005322960A1 (en) * 2005-01-06 2006-07-13 The Johns Hopkins University RNA interference that blocks expression of pro-apoptotic proteins potentiates immunity induced by DNA and transfected dendritic cell vaccines
JP2008528004A (ja) * 2005-01-26 2008-07-31 ザ ジョンズ ホプキンス ユニバーシティー 突然変異癌タンパク質抗原およびカルレティキュリンをコードするプラスミドを用いる抗癌ｄｎａワクチン
EP1920248B1 (de) 2005-04-05 2010-09-29 Allergan, Inc. Clostridientoxinaktivitätstests
CN103773804A (zh) * 2005-12-13 2014-05-07 国立大学法人京都大学 核重新编程因子
US20090227032A1 (en) 2005-12-13 2009-09-10 Kyoto University Nuclear reprogramming factor and induced pluripotent stem cells
US8278104B2 (en) * 2005-12-13 2012-10-02 Kyoto University Induced pluripotent stem cells produced with Oct3/4, Klf4 and Sox2
US8129187B2 (en) * 2005-12-13 2012-03-06 Kyoto University Somatic cell reprogramming by retroviral vectors encoding Oct3/4. Klf4, c-Myc and Sox2
US20100330105A1 (en) * 2006-08-22 2010-12-30 John Hopkins University Anticancer Combination Therapies
US9085638B2 (en) 2007-03-07 2015-07-21 The Johns Hopkins University DNA vaccine enhancement with MHC class II activators
US20080260765A1 (en) * 2007-03-15 2008-10-23 Johns Hopkins University HPV DNA Vaccines and Methods of Use Thereof
JP2008307007A (ja) * 2007-06-15 2008-12-25 Bayer Schering Pharma Ag 出生後のヒト組織由来未分化幹細胞から誘導したヒト多能性幹細胞
US9213999B2 (en) * 2007-06-15 2015-12-15 Kyoto University Providing iPSCs to a customer
US20090285861A1 (en) * 2008-04-17 2009-11-19 Tzyy-Choou Wu Tumor cell-based cancer immunotherapeutic compositions and methods
CN101855350B (zh) 2008-05-02 2014-12-31 国立大学法人京都大学 核重编程序方法
US8460674B2 (en) 2009-02-07 2013-06-11 University Of Washington HSV-1 epitopes and methods for using same
EP2413950A4 (de) 2009-04-03 2013-05-01 Univ Washington Antigenes hsv-2-peptid und verwendungsverfahren dafür
AU2010348409B2 (en) 2010-03-18 2014-03-20 Spiber Technologies Ab Production of proteins and polypeptides
US9845457B2 (en) 2010-04-30 2017-12-19 Cedars-Sinai Medical Center Maintenance of genomic stability in cultured stem cells
WO2013184527A1 (en) 2012-06-05 2013-12-12 Capricor, Inc. Optimized methods for generation of cardiac stem cells from cardiac tissue and their use in cardiac therapy
EP3563859B1 (de) 2012-08-13 2021-10-13 Cedars-Sinai Medical Center Von kardiosphären abgeleitete exosomen zur geweberegeneration
ES2993671T3 (en) 2013-03-15 2025-01-03 Univ Texas Peptide fttftvt for use in treating fibrosis
US20150023932A1 (en) * 2013-07-17 2015-01-22 Ke-Ke Fan Engineered peptide (ep)-directed protein intercellular delivery system and uses thereof
EP3169310A1 (de) 2014-07-15 2017-05-24 Life Technologies Corporation Zusammensetzungen mit lipidaggregaten und verfahren zur effizienten bereitstellung von molekülen an zellen
WO2016054591A1 (en) 2014-10-03 2016-04-07 Cedars-Sinai Medical Center Cardiosphere-derived cells and exosomes secreted by such cells in the treatment of muscular dystrophy
EA201891614A1 (ru) 2016-01-11 2019-02-28 Те Борд Оф Трастиз Оф Те Лилэнд Стэнфорд Джуниор Юниверсити Химерные белки и способы иммунотерапии
KR102917220B1 (ko) 2016-01-11 2026-01-22 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 키메라 단백질 및 유전자 발현을 조절하는 방법
EP3402543B1 (de) 2016-01-11 2021-09-08 Cedars-Sinai Medical Center Aus kardiosphäre stammende zellen und durch solche zellen sekretierte exosomen in der behandlung von herzversagen mit konservierter auswurffraktion
WO2017210652A1 (en) 2016-06-03 2017-12-07 Cedars-Sinai Medical Center Cdc-derived exosomes for treatment of ventricular tachyarrythmias
WO2018057542A1 (en) 2016-09-20 2018-03-29 Cedars-Sinai Medical Center Cardiosphere-derived cells and their extracellular vesicles to retard or reverse aging and age-related disorders
US11759482B2 (en) 2017-04-19 2023-09-19 Cedars-Sinai Medical Center Methods and compositions for treating skeletal muscular dystrophy
WO2019126068A1 (en) 2017-12-20 2019-06-27 Cedars-Sinai Medical Center Engineered extracellular vesicles for enhanced tissue delivery
EP3749344A4 (de) 2018-02-05 2022-01-26 Cedars-Sinai Medical Center Verfahren zur therapeutischen verwendung von exosomen und y-rnas
WO2020055812A1 (en) 2018-09-10 2020-03-19 Lung Therapeutics, Inc. Modified peptide fragments of cav-1 protein and the use thereof in the treatment of fibrosis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5747641A (en) * 1989-12-21 1998-05-05 Biogen Inc Tat-derived transport polypeptide conjugates
NO312681B1 (no) * 1990-08-24 2002-06-17 Univ California Fremgangsmåte for fremstilling av en farmasöytisk blanding med suppresiv virkning/aktivitet
FR2736915B1 (fr) * 1995-07-19 1997-08-22 Rhone Poulenc Rorer Sa Variants de la proteine p53 et utilisations therapeutiques
EP0845043B1 (de) * 1995-07-28 2007-06-27 Marie Curie Cancer Care Transportproteine und deren verwendungen
US6017735A (en) * 1997-01-23 2000-01-25 Marie Curie Cancer Care Materials and methods for intracellular transport and their uses

Also Published As

Publication number Publication date
JP2001508304A (ja) 2001-06-26
US20020106378A1 (en) 2002-08-08
CA2278002A1 (en) 1998-07-30
AU735830B2 (en) 2001-07-19
WO1998032866A1 (en) 1998-07-30
DE69834022D1 (de) 2006-05-18
AU5674998A (en) 1998-08-18
EP0961829A1 (de) 1999-12-08
US6251398B1 (en) 2001-06-26
EP0961829B1 (de) 2006-03-29
ES2264809T3 (es) 2007-01-16
DE69834022T2 (de) 2007-04-12
US20040197346A1 (en) 2004-10-07
US6017735A (en) 2000-01-25

Similar Documents

Publication Publication Date Title
ATE321869T1 (de) Fusionproteine für intra- und interzelluläre transport und deren verwendungen
DE69522216D1 (de) Zielzellen-bindende chimäre Peptide
DE60026164D1 (de) Virale kernproteine-kationische lipid-nukleinsäure-verabreichungkomplexe
AU3192889A (en) T cell activation markers
AU5099293A (en) CD27 ligand
BRPI9811940A (pt) vetor de expressão para um polipeptídeo de ligação da interleucina-18 (il-18-bp), célula hospedeira procariótica transformada com o referido vetor, processo para produção de il-18-bp, proteína de fusão compreendendo o referido polipeptídeo, bem como il-18bp modificada.
NZ504548A (en) Polypeptides and nucleic acids encoding human chordin
AU3867789A (en) Recombinant mycobacterial expression vehicles and uses therefor
CZ63995A3 (en) Virus vectors and their use in gene therapy
AU2001278797A1 (en) Expression vector using for animal cell
BG102554A (en) Vectors and methods for gene transfer into cells
EP2316479A3 (de) Pharmazeutische Zusammensetzungen, die immunologisch aktive Herpes simplex Virus Proteinfragmente enthalten
AU2682388A (en) Diagnostic system
DE69535719D1 (de) Fas-antigenbindender ligand
DK202586D0 (da) Partikler med immunogene egenskaber svarende til antigen hbs, vektorerog animalske celler til produktion af saadanne partikler samt anvendelse af disse til fremstilling af blandede vacciner
DE3686579D1 (en) Prokaryotisches expressionssystem.
DK1021553T3 (da) Eukaryotisk genekspressionskassette og anvendelser deraf
AU2751392A (en) Vaccines for actinobacillus pleuropneumoniae
EP0331356A3 (de) Expression von HIV-bindenden Proteinen
IL90334A0 (en) Genetic transformation of b.thuringiensis,vectors used therefor,host cells transformed by the vectors and use of said cells as insecticides
EP0805204A3 (de) Nebenhoden-spezifisches Rezeptorprotein und dessen Verwendung
AU5776799A (en) Modified hcv peptide vaccines
AU590861B2 (en) New human lymphotoxin (TNF-beta) polypeptides their prepartion and use
CA2283536A1 (en) Compositions and methods for elimination of unwanted cells
WO2001059073A3 (en) Cytotoxic t lymphocytes activated by dendritic cell hybrids

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties